Trials / Completed
CompletedNCT01937767
Remimazolam Phase II Cardiac Anesthesia Study
A Randomized, Single-blind Phase II Study Evaluating the Efficacy, Safety and Pharmacokinetics of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the PACU/ICU
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Paion UK Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This phase II study in patients undergoing elective cardiac surgery will evaluate the efficacy, safety, and pharmacokinetics of remimazolam, compared with propofol and sevoflurane, during the induction and maintenance of general anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | |
| DRUG | Propofol | |
| DRUG | Sevoflurane | |
| DRUG | Remifentanil | |
| DRUG | Fentanyl | |
| DRUG | Rocuronium |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-19
- First posted
- 2013-09-10
- Last updated
- 2020-01-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01937767. Inclusion in this directory is not an endorsement.